BGLC NASDAQ Week ended 07 Aug 2026

Weekly Investor Report

BioNexus Gene Lab Corp Common stock · Basic Materials · Specialty Chemicals

Open interactive chart View report data
Latest close 1.64 USD
24.2% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -26.1% below the Trend Line and sits at 11.3% of its 52-week range. The latest completed week returned 24.2%, after a -9.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal; earnings are due in 4d.

Setup score 15 out of 100
Latest Close 1.64 USD 7 Aug 2026
1W Return 24.2% latest completed week
4W Return -9.4% short-term follow-through
12W Return -18.8% quarterly tape
Trend Breadth 28.8% 15 of 52 weeks active
Volume Ratio 0.3x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 24.2% Latest completed week; four-week move -9.4%. Indicator stack 16/22 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 36.01% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 51/100 40 relevant articles in the latest sentiment read. Event risk 4d Next report is scheduled for 17 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -26.1% below the Trend Line and sits at 11.3% of its 52-week range. The latest completed week returned 24.2%, after a -9.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2312-week average 0.14

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.23Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -9.4% over four weeks, -18.8% over 12 weeks, and -70.6% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W24.2%
4W-9.4%
12W-18.8%
26W-22.3%
52W-70.6%
Active trend streak0 weeks
Active weeks in one year15
Trend breadth28.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.49Latest activity-pressure read.
Pressure change-243.1%Four-week change in activity pressure.
Leadership-58.11Latest relative-leadership reading.
RS change0.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 85% Model confidence 79%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength71/100Blend of value, momentum, and quality. Underlying universe rank 30; rank 1 is best.
Value61/100Relative valuation strength. Underlying universe rank 40; rank 1 is best.
Quality58/100Profitability and accounting quality. Underlying universe rank 43; rank 1 is best.
Momentum60/100Medium-term price momentum. Underlying universe rank 41; rank 1 is best.
Growth61/100Revenue and earnings growth. Underlying universe rank 40; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
13.5%
Gross profit retained from each unit of revenue.
Operating margin
-54.5%
Operating profit retained from revenue.
Free-cash-flow margin
-21.3%
Free cash flow generated from revenue.
Return on invested capital
-49.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-42.7%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.6%
Cash dividends relative to market value.
Buyback yield
-
Net share repurchases relative to market value.
Shareholder yield
-
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment51/100

Weighted news tone is neutral across 40 relevant articles.

5 positive · 29 neutral · 6 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings4dNext report is scheduled for 17 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-73.1%Distance below the 52-week high.
13-week volatility13.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 2617 weeks finished lower.
Best week+24.2%Week of 7 Aug.
Worst week-20.7%Week of 26 Jun.
Latest week+24.2%Week of 7 Aug.

Shape of recent returns

Strong gains6
Modest gains3
Flat weeks0
Modest losses7
Sharp losses10
Recent vol13.0%13-week weekly-return volatility.
Base vol9.0%52-week weekly-return volatility.
Up/down split17/35Count of positive and negative weeks in the 52-week window.
Average skew7.6% / -6.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape16/100

Trend, activity pressure, participation, and risk combine to a 16/100 tape read.

 Indicator analysis28/100

Latest 12-week confirmation: trend 0/12, activity pressure 9/12, relative leadership 0/12.

Activity pressure 0.23; No reversal markers Next-Week ExpectancyNegative 36.01%

Next-week expectancy is negative with a 36.01% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors62/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 50 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment51/100

Weighted news tone is neutral across 40 relevant articles.

Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury Insiders50/100

No recent insider transaction evidence is stored.

 Earnings4d

Next report is scheduled for 17 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20261.64 USD24.2%2.22 USD4.46 USD-0.49-58.11147.5KOff
31 Jul 20261.32 USD-12.6%2.30 USD4.52 USD-0.45-65.48122.9KOff
24 Jul 20261.51 USD-9.0%2.38 USD4.63 USD-0.18-61.6021.1KOff
17 Jul 20261.66 USD-8.3%2.47 USD4.81 USD0.03-59.3434.3KOff
10 Jul 20261.81 USD-10.8%2.56 USD5.19 USD0.34-58.4231.9KOff
3 Jul 20262.03 USD-1.9%2.63 USD6.00 USD0.56-53.5316.9KOff
26 Jun 20262.07 USD-20.7%2.70 USD6.32 USD0.55-53.4879.3KOff
19 Jun 20262.61 USD22.0%2.79 USD6.48 USD0.72-44.35250.3KOff
12 Jun 20262.14 USD-2.7%2.85 USD6.83 USD0.57-53.435.1MOff
5 Jun 20262.20 USD-5.2%2.93 USD6.99 USD0.44-51.3525.4KOff
29 May 20262.32 USD15.1%3.02 USD7.19 USD0.45-51.41524.7KOff
22 May 20262.02 USD-0.2%3.13 USD7.30 USD0.24-57.2326.6KOff
15 May 20262.02 USD-2.0%3.23 USD7.53 USD0.17-57.0033.6KOff
8 May 20262.06 USD-0.9%3.33 USD7.83 USD0.03-56.6016.5KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context